AGO2 and neoplasm: Furthermore, a 5′RACE assay on the RNA extracted from the treated xenograft tumour suggests specific survivin mRNA cleavage at the expected siRNA cut site through the Argonaute2 (Ago2) mechanism (Fig. 1c).